contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

OssDsign är en utvecklare och leverantör av ortobiologiska produkter. Bolaget utvecklar och marknadsför produkter som stödjer kroppens egen läkningsförmåga, exempelvis OssDsign Catalyst, som är ett nanosyntetiskt bentransplantat för dubbla benbildningsvägar genom fusionsmassa. Bolaget erbjuder sina produkter runtom den globala marknaden. OssDsign grundades 2011 och har sitt huvudkontor i Uppsala.

OssDsign

* 35% organic sales growth in Q3 (ABGSCe +38%)Adj. EBIT +37% vs ABGSCe* No change in outlookQ3 resultsOssDsign reported a mixed set of numbers in Q3 with lower sales but strong cost control ...

* 35% organic sales growth in Q3 (ABGSCe +38%)Adj. EBIT +37% vs ABGSCe* No change in outlookQ3 resultsOssDsign reported a mixed set of numbers in Q3 with lower sales but strong cost control and operational leverage. Q3 sales came in at SEK 44.2m (-4% vs ABGSCe SEK 46.2m, no consensus) and adj. EBIT of SEK 5.3m, +37% vs ABGSCe of -8.5m. The beat on adj. EBIT is attributable to lower opex as sales came in below and gross was marginally lower at 95.2% in the quarter (vs ABGSCe 95.5%). We are pleased to see that the 'sales and commission and fees' as percentage of sales came in better (ie lower) than expected at 48.5% (ABGSCe 49.0%). Sales in Q3 was negatively impacted by the late order (SEK 1.5m) that came in very late in Q2, which we to some extent tried to incorporate into our estimates. Still, sales came in 4% below. Organic sales growth in Q3 amounted to 35% (ABGSCe 38%)Webcast at 11.00 CET today, link: https://www.finwire.tv/webcast/ossdsign/q3-2025/EstimatesCompany is not providing any outlook for 2025 or changing its mid-term financial targets of reaching sales of SEK &gt;400m by 2028 and to become cash flow and EBIT positive in the second half of its 'Strategy Period' (2025-2028). Based on the deviation on EBIT in Q3, we expect FY'25e EBIT to be revised up (lower loss) by mid- to high single digit.Share price viewThe stock has been strong YTD (+30%) but a bit soft into the report (-3.5%, -5d). Based on the deviation and recent share price movements, we expect to see a positive share price reaction in similar magnitude as the estimated earnings revisions.

OssDsign: Strong cost control in Q3 - ABG

USA:s Black Week ledde till överraskande inköp

Måste man arbeta långa dagar? Ekonomen funderar

Uppgångsvecka bakom oss, Tyskland gick vidare med sin megabudget

Finlands ekonomiska tillväxt: ”Varje dag och varje natt tänker jag på dig”

Nedgångsvecka bakom oss, AI-oron når även obligationsmarknaden